6/26/2015 | PP | Generex concludes $500,000 private placement of convertible preferreds
|
3/28/2014 | PP | Generex concludes $2.08 million sale of convertible preferred stock
|
1/15/2014 | PP | Generex completes $2.03 million sale of convertible preferred stock
|
6/18/2013 | PP | Generex concludes $1.23 million sale of convertible preferred stock
|
12/11/2012 | PP | Generex completes $750,000 placement of convertible preferred stock
|
8/8/2012 | PP | Generex negotiates $750,000 placement of convertible preferred stock
|
1/31/2012 | PP | Generex negotiates $2 million offering of convertible preferred stock
|
7/11/2011 | PP | Generex arranges $5.15 million offering of convertible preferred stock
|
1/25/2011 | PP | Generex orchestrates $6 million registered direct offering of stock
|
4/8/2010 | PP | New Issue: Generex arranges $23.37 million registered direct offering of stock
|
9/14/2009 | PP | New Issue: Generex orchestrates $12.25 million registered direct offering of stock
|
9/14/2009 | PP | Market Commentary: Navigator plans PIPE; Generex eyes direct offering; Commerce Resources wraps upsized units
|
8/6/2009 | PP | New Issue: Generex Biotechnology plans $5.65 million offering of stock, warrants
|
6/15/2009 | PP | New Issue: Generex Biotechnology seals $10.99 million direct offering of stock
|
5/18/2009 | PP | New Issue: Generex Biotechnology completes $5 million registered direct offering of equity
|
5/18/2009 | PP | Market Commentary: Generex announces direct offering; Apex closes stock deal; First Century wraps $4.9 million sale
|
4/6/2009 | PP | Generex satisfies obligations under forbearance agreement
|
3/27/2009 | PP | Generex once again extends 8% convertible notes forbearance agreement to April 3
|
3/20/2009 | PP | Generex extends 8% convertibles forbearance agreement to March 27
|
3/2/2009 | PP | Generex negotiates forbearance agreement in regard to 8% convertible notes
|
12/23/2008 | PP | Generex, investors agree to amend 8% convertibles to cure default
|
4/2/2008 | PP | Market Commentary: MDwerks raises $7.5 million; Raptor, National Holdings sell to funds; Generex sells convertibles
|
4/2/2008 | PP | New Issue: Generex secures $20.65 million from sale of convertible notes, warrants
|
6/2/2006 | PP | Market Commentary: Jed Oil wraps $34.33 million convertible offering; Jones Soda secures $30 million from stock sale
|
6/2/2006 | BTPP | New Issue: Generex raises $7 million from private placement of stock
|
2/28/2006 | BTPP | Generex Biotechnology accelerates expiry on warrants issued in 2005
|
1/24/2006 | BTPP | Generex accelerates expiry of warrants from September, December 2005 AIRs
|
1/20/2006 | BTPP | New Issue: Generex raises $4 million from exercise of additional investment rights
|
12/5/2005 | BTPP | New Issue: Generex raises $3.5 million from exercise of additional investment rights
|
10/31/2005 | BTPP | New Issue: Generex Biotechnology raises additional $500,000 from exercise of AIRs
|
9/9/2005 | BTPP | Investors in 2004 Generex debenture offering exercise, receive amended additional investment rights
|
6/16/2005 | BTPP | New Issue: Generex prices $2 million convertible debentures
|
11/10/2004 | PP | New Issue: Generex gets agreements for $4 million in private placement of debentures
|
11/10/2004 | PP | Market Commentary: Private placement volume strengthens on better oil prices; Inhibitex closes $50 million deal
|